Lovenox and Hydrocephalus - a phase IV clinical study of FDA data

Summary:

Hydrocephalus is reported as a side effect among people who take Lovenox (enoxaparin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Decadron, and have Colitis.

The phase IV clinical study analyzes which people have Hydrocephalus when taking Lovenox. It is created by eHealthMe based on reports of 47,547 people who have side effects when taking Lovenox from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Hydrocephalus?

Hydrocephalus (water on the brain) is found to be associated with 751 drugs and 1,370 conditions by eHealthMe. Check the latest studies of Hydrocephalus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

47,547 people reported to have side effects when taking Lovenox.
Among them, 58 people (0.12%) have Hydrocephalus.

Among these 58 people:

How long have people been on Lovenox when they have Hydrocephalus? *

What is the gender of people who have Hydrocephalus when taking Lovenox? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Hydrocephalus when taking Lovenox? *

What are other drugs people take besides Lovenox? *

What are other side effects people have besides Hydrocephalus? *

Nuclear Magnetic Resonance Imaging Brain Abnormal: 15 people, 25.86%
Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 14 people, 24.14%
High Blood Pressure: 12 people, 20.69%
Nausea And Vomiting: 12 people, 20.69%
Unresponsive To Stimuli: 10 people, 17.24%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 10 people, 17.24%
Pneumonia: 9 people, 15.52%
Intraventricular Haemorrhage (intraventricular bleeding): 9 people, 15.52%
Headache (pain in head): 9 people, 15.52%
Cerebral Ventricle Dilatation (enlargement of ventricle of brain): 9 people, 15.52%

What are the existing conditions these people have? *

Colitis (inflammation of colon): 14 people, 24.14%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 17.24%
Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 7 people, 12.07%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 5 people, 8.62%
Pain: 5 people, 8.62%
Vena Cava Thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart): 4 people, 6.90%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 3 people, 5.17%
Medulloblastoma (a fast-growing, high-grade tumour that always begins in the cerebellum): 3 people, 5.17%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.17%
Inferior Vena Caval Occlusion: 2 people, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and have Hydrocephalus?

- Check whether Hydrocephalus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lovenox:

Lovenox (48,149 reports)

Hydrocephalus treatments and more:

Hydrocephalus (6,876 reports)

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hydrocephalus:

Hydrocephalus (751 drugs)

Browse all the conditions that are associated with Hydrocephalus:

Hydrocephalus (1,370 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Lovenox) and Lovenox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.